AU4697499A - Egg surface proteins and methods for use for modulating fertility - Google Patents

Egg surface proteins and methods for use for modulating fertility

Info

Publication number
AU4697499A
AU4697499A AU46974/99A AU4697499A AU4697499A AU 4697499 A AU4697499 A AU 4697499A AU 46974/99 A AU46974/99 A AU 46974/99A AU 4697499 A AU4697499 A AU 4697499A AU 4697499 A AU4697499 A AU 4697499A
Authority
AU
Australia
Prior art keywords
methods
surface proteins
egg surface
modulating fertility
fertility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU46974/99A
Inventor
Scott A. Coonrod
John C. Herr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Virginia Patent Foundation
Original Assignee
University of Virginia UVA
University of Virginia Patent Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Virginia UVA, University of Virginia Patent Foundation filed Critical University of Virginia UVA
Publication of AU4697499A publication Critical patent/AU4697499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
AU46974/99A 1998-06-19 1999-06-18 Egg surface proteins and methods for use for modulating fertility Abandoned AU4697499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8995098P 1998-06-19 1998-06-19
US60089950 1998-06-19
PCT/US1999/013858 WO1999065520A1 (en) 1998-06-19 1999-06-18 Egg surface proteins and methods for use for modulating fertility

Publications (1)

Publication Number Publication Date
AU4697499A true AU4697499A (en) 2000-01-05

Family

ID=22220352

Family Applications (1)

Application Number Title Priority Date Filing Date
AU46974/99A Abandoned AU4697499A (en) 1998-06-19 1999-06-18 Egg surface proteins and methods for use for modulating fertility

Country Status (4)

Country Link
EP (1) EP1085903A1 (en)
JP (1) JP2002518344A (en)
AU (1) AU4697499A (en)
WO (1) WO1999065520A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7019114B2 (en) 1998-02-19 2006-03-28 Eastern Virginia Medical School Recombinant, biologically active human zona pellucida protein 3 (HZP3) to test male fertility
US7037663B2 (en) 1998-02-19 2006-05-02 Eastern Virginia Medical School Human zona pellucida protein 3 and uses thereof
AU782467B2 (en) * 2000-01-20 2005-07-28 University Of Virginia Patent Foundation Egg specific surface proteins
CA2456821A1 (en) 2001-08-02 2003-02-13 Trinity Biomedical Technology Corporation Human zona pellucida proteins and methods of their use in diagnosing male infertility
DE10143346A1 (en) * 2001-09-04 2003-03-27 Xzillion Gmbh & Co Kg Process for the separation of reversibly chemically modified macromolecules
JP2006516896A (en) * 2003-01-10 2006-07-13 ユニバーシティ オブ バージニア パテント ファウンデーション ePAD, oocyte-specific protein
WO2008026906A1 (en) * 2006-08-25 2008-03-06 Instituto Nacional De Ciencias Médicas Y Nutrición Salvador Zubirán Sperm capture assay using proteins zp2, zp3 and zp4
WO2014120975A1 (en) * 2013-02-01 2014-08-07 California Institute Of Technology Antibody-mediated immunocontraception
US10966414B2 (en) 2015-05-26 2021-04-06 California Institute Of Technology Population control using engineered translocations
US11965172B2 (en) 2018-11-05 2024-04-23 California Institute Of Technology DNA sequence modification-based gene drive

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641487A (en) * 1989-06-12 1997-06-24 The Government Of The United States Of America As Represented By The Secretary Department Of Health And Human Services Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides

Also Published As

Publication number Publication date
WO1999065520A1 (en) 1999-12-23
EP1085903A1 (en) 2001-03-28
JP2002518344A (en) 2002-06-25

Similar Documents

Publication Publication Date Title
AU1931899A (en) Optoacoustic contrast agents and methods for their use
AU8766098A (en) Assay methods and apparatus
AU1624699A (en) Apparatus and method for determining tissue characteristics
AU2434199A (en) Protein
AU8127498A (en) Device and method for inspecting surface
AU1701599A (en) Methods for modulating and identifying cellular senescence
AU5340399A (en) Proteases and associated proteins
AU5871298A (en) Methods for making geopolymeric cements and cements resulting from these methods
AU4100199A (en) Compositions and methods for enhancing protein anabolism and detoxification
AU2787097A (en) Methods and apparatus for position determination
AU4697499A (en) Egg surface proteins and methods for use for modulating fertility
AU4992299A (en) Uncoupling protein 4 (ucp-4) and methods of use
AU5551299A (en) Method of identifying proteins
AU3241895A (en) Apoptosis related protein bcl-y, and methods of use thereof
AU3288497A (en) Mammalian tolloid-like gene and protein
AU4686299A (en) Nek-related and bub1-related protein kinases
AU2541397A (en) Tissue remodeling proteins
AU7936698A (en) Method for inferring protein functions with the use of ligand data base
AU3656497A (en) Traf2-associated protein kinase and assays
AU6331398A (en) Methods and additives for microtagging fluids
AU1126000A (en) Proliferation and apoptosis related proteins
AU4974299A (en) Methods and constructs for protein expression
AU9807398A (en) Single photon-emitting radiotraces and methods for their use
AUPN024994A0 (en) Assay and peptides for use therein
IL147345A0 (en) Drosphila recombination- associated protein and methods for use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase